Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620826 · ClinicalTrials.gov registry record · NA
Prospective Comparison of Indirect Pulp Therapy and Mineral Trioxide Aggregate Pulpotomy in Decayed Primary Molars
A NA study of Dental Pulp Capping, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT02620826: Completed NA study of Dental Pulp Capping, sponsored by University of Michigan.
NCT02620826 is a NA study of Dental Pulp Capping that has completed, run by University of Michigan. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02620826, a NA study of Dental Pulp Capping, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective study compares the use of indirect pulp therapy and mineral trioxide aggregate pulpotomy for pulp therapy of the primary molar with dental caries approaching the pulp.
Primary Outcome
Pain, mobility, abscess as determined with clinical evaluation
Conditions Studied
Interventions
- PROCEDURE Indirect pulp therapy
- PROCEDURE Pulpotomy
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2013-12 |
| Est. Completion | 2019-12 |
| Phase | NA |
What the finished NCT02620826 record still lists
NCT02620826 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Dental Pulp Capping appearing as the primary indexed condition, and to 2 interventions - of which Indirect pulp therapy is the first listed.
NCT02620826 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02620826 about?
NCT02620826 is a clinical study titled "Prospective Comparison of Indirect Pulp Therapy and Mineral Trioxide Aggregate Pulpotomy in Decayed Primary Molars". This prospective study compares the use of indirect pulp therapy and mineral trioxide aggregate pulpotomy for pulp therapy of the primary molar with dental caries approaching the pulp.
What is the current status of trial NCT02620826?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2013-12. Estimated completion is 2019-12.
What conditions does trial NCT02620826 study?
This clinical trial studies the following conditions: Dental Pulp Capping.
What interventions are being tested in trial NCT02620826?
The interventions under investigation include: Indirect pulp therapy (PROCEDURE), Pulpotomy (PROCEDURE).
Who is sponsoring clinical trial NCT02620826?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02620826 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02620826's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia